Physician profile
Michael A Rauh
NPI 1205985645
$37,790.96
in general payments reported to CMS, 2019-2025
8 companies · $860 in 2025
The $860 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $13K · 2021: $172 · 2022: $1,322 · 2023: $1,878 · 2024: $291 · 2025: $860.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,163 · Food and Beverage: $867.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,162.87 |
| Food and Beverage | $866.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $26,170.63 | 2019-2023 | Easy Clip |
| Smith+Nephew, INC. | $9,514.93 | 2019-2025 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Prodigy Surgical Distribution, INC. | $1,208.33 | 2022 | |
| Arthrex, INC. | $814.33 | 2025 | |
| Pacira Therapeutics, INC. | $31.80 | 2019 | |
| Ferring Pharmaceuticals INC. | $25.48 | 2021 | |
| Novo Nordisk INC | $18.37 | 2021 | |
| Heraeus Medical, LLC. | $7.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Rauh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.